Ismail Elbaz Younes

Ismail Elbaz Younes serves as an Assistant Professor in the Department of Laboratory Medicine and Pathology at the University of Minnesota Medical School. His academic work focuses on hematologic malignancies with particular emphasis on myeloid neoplasms, leukemias, and lymphomas. Dr. Younes maintains an active research program analyzing molecular mechanisms, diagnostic criteria, and therapeutic approaches for various hematologic disorders.

Dr. Younes' research interests center on precision medicine in hematologic malignancies, with specific expertise in myeloproliferative neoplasms, chronic neutrophilic leukemia, and lymphoma subtypes. His work bridges laboratory medicine with clinical applications, particularly examining genetic insights that inform diagnosis and treatment strategies. He has made significant contributions to understanding DDX41 mutations, clonal hematopoiesis, and molecular markers in myeloid disorders.

His publication record demonstrates a clear trend toward increasingly sophisticated molecular analysis of hematologic malignancies, with recent work focusing on precision medicine approaches for polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Dr. Younes' research spans both original investigations and comprehensive review articles that synthesize current knowledge in specialized areas of hematopathology.

While specific awards aren't documented in the available information, Dr. Younes' work has gained recognition through citations and social media mentions, with several publications generating significant academic discussion.

Dr. Younes collaborates with a network of researchers across institutions, with frequent co-authorship patterns suggesting strong working relationships with colleagues including Mroz, Tashakori, Hamed, and Sen. His research appears to be supported through institutional academic channels, though specific grant information isn't detailed in the available materials.

Based on publication patterns and research focus areas, Dr. Younes appears to be part of a hematology/oncology research team at the University of Minnesota that specializes in molecular diagnostics and precision medicine approaches for hematologic malignancies, with particular expertise in myeloid neoplasms.